As demonstrated for the ETS family member FLI-1 (36), the functional outcome of an interaction of a target molecule with PIAS proteins also can be severely influenced by a PIAS-dependent targeting to specific nuclear substructures, especially promyelocytic leukemia nuclear bodies. The gene discussed is FLI1; the disease is acute promyelocytic leukemia.